Natco Pharma Ltd soars 1.05, Gains for third straight session - Business Standard
| NATCOPHARM | 1,463 29.45 1.97% |
Under 62% of Natco Pharma's investor base is looking to short. The analysis of overall sentiment of trading Natco Pharma Limited stock suggests that many investors are alarmed at this time. Natco Pharma's investing sentiment shows overall attitude of investors towards Natco Pharma Limited.
Natco |
Natco Pharma Ltd soars 1.05, Gains for third straight session Business Standard
Read at news.google.com
 |
Natco Pharma Fundamental Analysis
We analyze Natco Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Natco Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Natco Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Natco Pharma is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Natco Pharma Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Natco Pharma stock to make a market-neutral strategy. Peer analysis of Natco Pharma could also be used in its relative valuation, which is a method of valuing Natco Pharma by comparing valuation metrics with similar companies.
Peers
Natco Pharma Related Equities
| SMLT | Sarthak Metals | 3.97 | ||||
| HILTON | Hilton Metal | 2.34 | ||||
| GOKUL | Gokul Refoils | 2.08 | ||||
| SONATSOFTW | Sonata Software | 2.02 | ||||
| IMFA | Indian Metals | 1.88 | ||||
| AVALON | AVALON TECHNOLOGIES | 1.23 | ||||
| RAJMET | Rajnandini Metal | 1.51 | ||||
| ORIENTTECH | Orient Technologies | 1.87 |
Complementary Tools for Natco Stock analysis
When running Natco Pharma's price analysis, check to measure Natco Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Natco Pharma is operating at the current time. Most of Natco Pharma's value examination focuses on studying past and present price action to predict the probability of Natco Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Natco Pharma's price. Additionally, you may evaluate how the addition of Natco Pharma to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance |